Semma Therapeutics
New class of regenerative medicine therapies couples its breakthrough stem cell technologies with proprietary delivery systems designed to protect cells from the immune system.
Enterprise value
$950m
Recent deals
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
$950m Valuation: $950m | Acquisition | ||
| Total Funding | 000k | ||
F-Prime(exited)
Medtronic(exited)
MPM BioImpact(exited)
ARCH Venture Partners(exited)
JDRF T1D Fund(exited)
Novartis(exited)
Eight Roads Ventures(exited)
6 Dimensions Capital(exited)
Harvard University(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Semma Therapeutics
Edit
ACQUISITION by Semma Therapeutics Aug 2015